ASCO/EHA/ICML 2021 – Christian Buske

Christian Buske relates to recent developments with respect to the role of BTK inhibitors and their potential future combination partners in the treatment of patients with Waldenström’s macroglobulinemia, the results of the iNNOVATE study and personalized treatment according to genotypes.

Here is the full ASCO/EHA/ICML 2021 report.